PDB31 A LIFETIME MODELLED ECONOMIC EVALUATION COMPARING PIOGLITAZONE AND ROSIGLITAZONE FORTHE TREATMENT OF TYPE-2 DIABETES MELLITUS IN THE UK
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67650-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)67650-4/fulltext
Title :
PDB31 A LIFETIME MODELLED ECONOMIC EVALUATION COMPARING PIOGLITAZONE AND ROSIGLITAZONE FORTHE TREATMENT OF TYPE-2 DIABETES MELLITUS IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67650-4&doi=10.1016/S1098-3015(10)67650-4
First page :
Section Title :
Open access? :
No
Section Order :
234